Table 4

Gene amplifications detected by array CGH

GeneHormone-sensitive tumorsHormone-escaped tumorsP
AmplificationsTumorsPercentageAmplificationsTumorsPercentage
MET 31618.750190.000.250
PTPN1 21811.110180.000.500
KRAS2 41921.051185.560.375
HER2 31915.791185.561.000
MYCN 31816.6721811.111.000
D17S1670 1195.2621811.111.000
CBFA2 31816.6731915.791.000
IGFR1 21910.5331915.791.000
TERC 1185.5631915.790.500
HRAS 1195.2631915.790.500
MYC 0180.0031915.790.250
CSE1L 21513.3331816.670.500
JUNB 1185.5631816.670.500
RAF1 1195.2631816.670.500
FGFR1 0180.0031717.650.250
MYBL2 21910.5341921.050.625
GARP 1175.8841822.220.250
CTSB 51729.4161931.581.000
ESR 41822.2261931.580.625
STK15 51827.7861833.331.000
SAS/CDK4 31816.6761833.330.250
FGR(Src-2) 0190.0071936.840.016
LAMC2 51827.7871838.890.500
PGY1 31520.0071838.890.375
MYB 31915.7981942.110.063
FGFR2 91850.0081844.441.000
NRAS 91947.3791947.371.000
MYCL1 41822.2291947.370.125
PI3K 71838.8991850.000.375
AR 121963.16101567.231.000